Advertisement

Antiplatelet Antibodies in Chronic Immune Thrombocytopenia and Their Role in Platelet Destruction and Defective Platelet Production

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Hematology/Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • George J.N.
        • Woolf S.H.
        • Raskob G.E.
        • et al.
        Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
        Blood. 1996; 88: 3-40
        • Harrington W.J.
        • Sprague C.C.
        • Minnich V.
        • et al.
        Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura.
        Ann Intern Med. 1953; 38: 433-469
        • Shulman N.R.
        • Marder V.J.
        • Weinrach R.S.
        Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic, and isotopic studies.
        Ann NY Acad Sci. 1965; 124: 499-542
        • Kelton J.G.
        • Powers P.J.
        • Carter C.J.
        A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura.
        Blood. 1982; 60: 1050-1053
        • Mueller-Eckhardt C.
        • Kayser W.
        • Mersch-Baumert K.
        • et al.
        The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders.
        Br J Haematol. 1980; 46: 123-131
        • van Leeuwen E.F.
        • van der Ven J.T.H.
        • Engelfriet C.P.
        • et al.
        Specificity of autoantibodies in autoimmune thrombocytopenia.
        Blood. 1982; 59: 23-26
        • McMillan R.
        • Tani P.
        • Millard F.
        • et al.
        Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP.
        Blood. 1987; 70: 1040-1045
        • Kiefel V.
        • Santoso S.
        • Weisheit M.
        • et al.
        Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies.
        Blood. 1987; 70: 1722-1726
        • Brighton T.A.
        • Evans S.
        • Castaldi P.A.
        • et al.
        Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias.
        Blood. 1996; 88: 194-201
        • Warner M.N.
        • Moore J.C.
        • Warkentin T.E.
        • et al.
        A prospective study of protein-specific assays used to investigate idiopathic thrombocytopenic purpura.
        Br J Haematol. 1999; 104: 442-447
        • McMillan R.
        • Wang L.
        • Tani P.
        Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP).
        J Thromb Haemost. 2003; 1: 485-491
        • Fujisawa K.
        • Tani P.
        • Piro L.
        • et al.
        The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura.
        Blood. 1993; 81: 2872-2877
        • Olsson B.
        • Andersson P.
        • Jernas M.
        • et al.
        T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.
        Nat Med. 2003; 9: 1123-1124
        • Fabris F.
        • Scandellari R.
        • Ruzzon E.
        • et al.
        Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura.
        Blood. 2004; 103: 4562-4564
        • Varon D.
        • Karpatkin S.
        A monoclonal antiplatelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets.
        Proc Natl Acad Sci U S A. 1983; 80: 6992-6995
        • Hou M.
        • Stockelberg D.
        • Kutti J.
        • et al.
        Glycoprotein IIb/IIIa autoantigenic repertoire in chronic idiopathic thrombcytopenic purpura.
        Br J Haematol. 1995; 91: 971-975
        • Escher R.
        • Muller D.
        • Vogel M.
        • et al.
        Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP.
        Br J Haematol. 1998; 102: 820-828
        • Nugent D.J.
        Human monoclonal antibodies in the characterization of platelet antigens.
        in: Kunicki T. George J.N. Platelet immunobiology: molecular and clinical aspects. Lippincott, Philadelphia1989: 273-290
        • He R.
        • Reid D.M.
        • Jones C.E.
        • et al.
        Extracellular epitopes of platelet glycoprotein Iba reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura.
        Blood. 1995; 86: 3789-3796
        • McMillan R.
        • Lopez-Dee J.
        • Bowditch R.
        Clonal restriction of platelet-associated anti-GPIIb/IIIa autoantibodies in patients with chronic ITP.
        Thromb Haemost. 2001; 85: 821-823
        • Roark J.H.
        • Bussel J.B.
        • Cines D.B.
        • et al.
        Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation.
        Blood. 2002; 100: 1388-1398
        • Fujisawa K.
        • McMillan R.
        Platelet-associated antibody to glycoprotein IIb/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens.
        Blood. 1993; 81: 1284-1289
        • Kosugi S.
        • Tomiyama Y.
        • Shiraga M.
        • et al.
        Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
        Thromb Haemost. 1996; 75: 339-345
        • Bowditch R.D.
        • Tani P.
        • McMillan R.
        Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides.
        Br J Haematol. 1995; 91: 178-184
        • McMillan R.
        • Lopez-Dee J.
        • Loftus J.C.
        Autoantibodies to aIIbb3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on aIIb.
        Blood. 2001; 97: 2171-2172
        • Tomiyama Y.
        • Kurata Y.
        • Mizutani H.
        • et al.
        Platelet glycoprotein IIb as a target antigen in two patients with chronic immune thrombocytopenic purpura.
        Br J Haematol. 1987; 66: 535-538
        • McMillan R.
        • Wang L.
        • Lopez-Dee J.
        • et al.
        Many aIIbb3 autoepitopes are localized to aIIb between amino acids L1 and Q459.
        Br J Haematol. 2002; 118: 1132-1136
        • Kosugi S.
        • Tomiyama Y.
        • Honda S.
        • et al.
        Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of GPIIb.
        Blood. 2001; 98: 1819-1827
        • Askonas B.A.
        • Humphrey J.H.
        Formation of specific antibodies and g-globulin in vitro: a study of the synthetic ability of various tissues from rabbits immunized by different methods.
        Biochem J. 1958; 68: 252-261
        • McMillan R.
        • Longmire R.L.
        • Yelenosky R.
        • et al.
        Immunoglobulin synthesis in vitro by splenic tissue in idiopathic thrombocytopenic purpura.
        N Engl J Med. 1972; 286: 681-684
        • Karpatkin S.
        • Strick N.
        • Siskind G.W.
        Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP).
        Br J Haematol. 1972; 23: 167-176
        • McMillan R.
        • Longmire R.L.
        • Yelenosky R.
        • et al.
        Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura.
        N Engl J Med. 1974; 291: 812-817
        • McMillan R.
        • Luiken G.A.
        • Levy R.
        • et al.
        Antibody against megakaryocytes in idiopathic thrombocytopenic purpura.
        JAMA. 1978; 239: 2460-2462
        • McMillan R.
        • Yelenosky R.J.
        • Longmire R.L.
        Antiplatelet antibody production by the spleen and bone marrow in immune thrombocytopenic purpura.
        in: Battisto J.R. Streinlein J.W. Immunoaspects of the spleen. North Holland Biomedical Press, Amsterdam1976: 227-237
        • Harker L.A.
        Thrombokinetics in idiopathic thrombocytopenic purpura.
        Br J Haematol. 1970; 19: 95-104
        • Branehog I.
        • Kutti J.
        • Weinfeld A.
        Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP).
        Br J Haematol. 1974; 27: 127-143
        • Stoll D.
        • Cines D.B.
        • Aster R.H.
        • et al.
        Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia.
        Blood. 1985; 65: 584-588
        • Heyns A.P.
        • Badenhorst P.N.
        • Lotter M.G.
        • et al.
        Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111-In-labeled and homologous 51- Cr-labeled platelets differ.
        Blood. 1986; 67: 86-92
        • Ballem P.J.
        • Segal G.M.
        • Stratton J.R.
        • et al.
        Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence for both impaired platelet production and increased platelet clearance.
        J Clin Invest. 1987; 80: 33-40
        • Handin R.I.
        • Stossel T.P.
        Phagocytosis of antibody-coated platelets by human granulocytes.
        N Engl J Med. 1974; 290: 989-993
        • Zucker-Franklin D.
        • Karpatkin S.
        Red-cell and platelet fragmentation in idiopathic autoimmune thrombocytopenic purpura.
        N Engl J Med. 1977; 297: 517-523
        • McMillan R.
        • Longmire R.L.
        • Tavassoli M.
        • et al.
        In vitro platelet phagocytosis by ITP splenic leukocytes in idiopathic thrombocytopenic purpura.
        N Engl J Med. 1974; 290: 249-251
        • Tsubakio T.
        • Kurata Y.
        • Kanayama Y.
        • et al.
        In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura.
        Acta Haematol. 1983; 70: 250-256
        • Shulman N.R.
        • Weinrach R.S.
        • Libre E.P.
        • et al.
        The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura.
        Trans Assoc Am Physicians. 1965; 78: 374-390
        • Clarkson S.B.
        • Bussel J.B.
        • Kimberly R.P.
        • et al.
        Treatment of refractory immune thrombocytopenic purpura with anti-Fcg-receptor antibody.
        N Engl J Med. 1986; 314: 1236-1239
        • McMillan R.
        • Bowditch R.
        • Tani P.
        • et al.
        A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb/III a autoantibody.
        Br J Haematol. 1996; 95: 747-749
        • Hauch T.W.
        • Rosse W.F.
        Platelet-bound complement (C3) in immune thrombocytopenia.
        Blood. 1977; 50: 1129-1136
        • Kurata Y.
        • Curd J.G.
        • Tamerius J.D.
        • et al.
        Platelet-associated complement in chronic ITP.
        Br J Haematol. 1985; 60: 723-733
        • McMillan R.
        • Martin M.
        Fixation of the third component of complement (C3) to platelets in vitro by antiplatelet antibody for patients with ITP.
        Br J Haematol. 1981; 47: 251-256
        • Dameshek W.
        • Miller E.B.
        The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism.
        Blood. 1946; 1: 27-52
        • Pisciotta A.V.
        • Stefanini M.
        • Dameshek W.
        Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura.
        Blood. 1953; 8: 703-723
        • Diggs L.W.
        • Hewlett J.S.
        A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura.
        Blood. 1948; 3: 1090-1104
        • Stahl C.P.
        • Zucker-Franklin D.
        • McDonald T.P.
        Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP.
        Blood. 1986; 67: 421-428
        • Houwerzijl E.J.
        • Blom N.R.
        • van der Want J.J.L.
        • et al.
        Ultrastructural study shows morphological features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura.
        Blood. 2004; 103: 500-506
        • Heyns A.P.
        • Lotter M.G.
        • Badenhorst P.N.
        • et al.
        Kinetics and sites of destruction of 111-Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study.
        Am J Hematol. 1982; 12: 167-177
        • McMillan R.
        • Wang L.
        • Tomer A.
        • et al.
        Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients.
        Blood. 2004; 103: 1364-1369
        • Chang M.
        • Nakagawa P.A.
        • Williams S.A.
        • et al.
        Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.
        Blood. 2003; 102: 887-895
        • Bussel J.B.
        • Kuter D.J.
        • Pullarkat V.
        • et al.
        Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.
        Lancet. 2009; 113: 2161-2171
        • Bussel J.B.
        • Provan D.
        • Shamsi T.
        • et al.
        Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomized, double-blind, placebo-controlled trial.
        Lancet. 2009; 373: 641-648